Sacituzumab govitecan for treatment-refractory metastatic breast cancer

Sacituzumab govitecan for treatment-refractory metastatic breast cancer

VJOncology

1 year
67 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Aditya Bardia, MD, MPH, of Massachusetts General Hospital, Boston, MA, discusses the promising efficacy data of sacituzumab govitecan, an anti-Trop-2/SN-38 antibody-drug conjugate (ADC), for treatment-refractory HR+/HER2- metastatic breast cancer (NCT01631552). Prof. Bardia explains the next steps for the further development of this exciting agent, highlighting what indications this treatment is seeking approvals in. He also covers the potential of this ADC for early breast cancer and in combination with PARP inhibitors. This interview was recorded at the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL.
Up Next Autoplay
Who is Eligible for the AVIATOR Study? @SeattleCCA
Who is Eligible for the AVIATOR Study? @SeattleCCA
Category: Breast Cancer
2 Views
SeattleCCA 1 week
The AVIATOR Study @SeattleCCA
The AVIATOR Study @SeattleCCA
Category: Breast Cancer
2 Views
SeattleCCA 1 week
Roswell Park Breast Surgery Chief Gives Keynote Talk on Immunotherapy for Breast Cancer
Roswell Park Breast Surgery Chief Gives Keynote Talk on Immunotherapy for Breast Cancer
Category: Breast Cancer
7 Views
Roswell Park 2 weeks
Biomarkers with Locally Advanced Metastatic Carcinoma Results
Biomarkers with Locally Advanced Metastatic Carcinoma Results
Category: Breast Cancer
4 Views
UChicago Medicine 4 weeks
Biomarkers in Urothelial Carcinoma
Biomarkers in Urothelial Carcinoma
Category: Breast Cancer
30 Views
UChicago Medicine 4 weeks
Trends in Breast Cancer Death Rates
Trends in Breast Cancer Death Rates
Category: Breast Cancer
2 Views
Cancer-News 1 month
Breast Cancer Trends in U.S.
Breast Cancer Trends in U.S.
Category: Breast Cancer
13 Views
Cancer-News 1 month
Lower Costs in Breast Cancer: How This Affects Treatment
Lower Costs in Breast Cancer: How This Affects Treatment
Category: Breast Cancer
3 Views
ONeal Comprehensive Cancer Center 1 month
Lower Costs for Patients in Metastatic Breast Cancer
Lower Costs for Patients in Metastatic Breast Cancer
Category: Breast Cancer
28 Views
ONeal Comprehensive Cancer Center 1 month
Using Technology to Better Understand What Goes Wrong in Cancer
Using Technology to Better Understand What Goes Wrong in Cancer
Category: Breast Cancer
18 Views
Cancer-News 1 month